Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Melanoma

  Free Subscription


05.04.2021

1 Am J Surg
1 Ann Surg Oncol
1 Anticancer Res
1 Biochem Biophys Res Commun
1 Br J Dermatol
1 Cancer
1 J Immunol
2 J Invest Dermatol
1 J Surg Oncol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg

  1. ARNOT SP, Han G, Fortino J, Han D, et al
    Utility of a 31-gene expression profile for predicting outcomes in patients with primary cutaneous melanoma referred for sentinel node biopsy.
    Am J Surg. 2021 Mar 17. pii: S0002-9610(21)00163.
    PubMed         Abstract available


    Ann Surg Oncol

  2. AHMADI O, Das M, Hajarizadeh B, Mathy JA, et al
    Impact of Shave Biopsy on Diagnosis and Management of Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2021 Mar 29. pii: 10.1245/s10434-021-09866.
    PubMed         Abstract available


    Anticancer Res

  3. LEE Y, Park D
    Effect of Metformin in Combination With Trametinib and Paclitaxel on Cell Survival and Metastasis in Melanoma Cells.
    Anticancer Res. 2021;41:1387-1399.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  4. LOPES JC, Botelho FV, Barbosa Silva MJ, Silva SF, et al
    In vitro and in vivo antitumoral activity of a ternary copper (II) complex.
    Biochem Biophys Res Commun. 2020;533:1021-1026.
    PubMed         Abstract available


    Br J Dermatol

  5. MARLEY AR, Li M, Champion VL, Song Y, et al
    The Association between Citrus Consumption and Melanoma Risk in the UK Biobank.
    Br J Dermatol. 2021 Mar 30. doi: 10.1111/bjd.19896.
    PubMed         Abstract available


    Cancer

  6. KEMPF E, Zalcman G, Lebbe C
    National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?
    Cancer. 2021 Mar 31. doi: 10.1002/cncr.33495.
    PubMed        


    J Immunol

  7. OBA T, Hoki T, Yamauchi T, Keler T, et al
    A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
    J Immunol. 2020;205:1867-1877.
    PubMed         Abstract available


    J Invest Dermatol

  8. AL EMRAN A, Tseng HY, Gunatilake D, Cook SJ, et al
    A combination of epigenetic BET and CDK9 inhibitors for treatment of human melanoma.
    J Invest Dermatol. 2021 Mar 26. pii: S0022-202X(21)01121.
    PubMed         Abstract available

  9. HUANG SW, Wang ST, Chang SH, Chuang KC, et al
    Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
    J Invest Dermatol. 2020;140:1771-1783.
    PubMed         Abstract available


    J Surg Oncol

  10. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed         Abstract available


    PLoS One

  11. LEE YS, Heo W, Choi HJ, Cho HR, et al
    An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells.
    PLoS One. 2021;16:e0248870.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: